Animalcare stock holds near Charterhouse's 336p offer with clock ticking

London, June 16, 2026, 15:06 BST

Animalcare traded between 330p and 333p, under the 336p-a-share cash bid on the table.
New disclosures from Takeover Code filings reported routine dealing activity. Offer terms remain the same.
Investors are looking at a July 21 deadline to choose a reinvestment election. The court will hold its sanction hearing on July 28.

Animalcare Group PLC traded flat just under the bid price on Tuesday. Hargreaves Lansdown quoted Animalcare at 330p to sell and 333p to buy. No change. The FTSE AIM 100 slipped 0.24%. Animalcare’s 331.5p midpoint stayed a little under the 336p a share CCP Paw 2 Limited is offering in cash. Trading looked like takeover arbitrage instead of a reaction to earnings. HL

No indication of a different operating angle in the latest filings. Octopus Investments’ Form 8.3 shows it holds 3.91 million Animalcare shares, or 5.66%. Octopus sold some shares on June 15 at about £3.3208 each. Panmure Liberum submitted Form 8.5 with small trades for clients. These filings are regular Takeover Code steps during a bid. Animalcare shares have barely moved, holding at the offer price. Investegate

Animalcare shares are steady, with little change after the cash offer was announced. The April bid valued the business at £235.2 million, offering 336p per share in cash. Shares jumped 34% on the news, finishing at 332.01p in London, Alliance News reported. Chair Ed Torr said the deal gives “immediate value certainty in cash at an attractive premium.” That’s how the market is treating it now. Most holders see the takeover as already priced in. Morningstar

Legal completion is now at the front, ahead of any trading update. Animalcare said the Australian FIRB green light is in, with the Commonwealth Treasurer not objecting. The deal still needs OK from the court, registration of the court order, and ticking off any other outstanding or waived conditions. Investors who want the alternative offer must decide by 5 p.m. July 21. The court hearing to sanction the deal comes July 28, and Animalcare expects the scheme to kick in on July 30. The takeover is a scheme of arrangement, a process under UK courts that binds shareholders once the requirements are satisfied. Investegate

Animalcare backed the takeover bid, key shareholders have voted in favor, and Australian regulators have signed off. For 2025, Animalcare reported a 20.0% rise in revenue to £89.1 million, with underlying EBITDA up 52.6% to £17.7 million. The EBITDA number strips out interest, tax, depreciation, amortisation and management’s extra adjustments. Still, upside above 336p looks limited, there’s a risk the deal could still fall through, and management dropped the 2025 final dividend on the back of the buyout proposal. AIM-listed shares like Animalcare can be thinly traded. Animalcare is trading on the deal now, not on growth. The key questions for holders now are deal risk, timing, and whether there’s any more left in the price if the deal closes. Investegate

UK Government to Ease Electric Vehicle Sales Targets to 50% by 2030
June 16, 2026, 10:29 AM EDT. The UK government plans to lower its zero-emission vehicle (ZEV) sales targets from 80% to 50% by 2030, responding to industry and union lobbying. Current targets require a 33% EV sales mix in 2026, rising to 80% by 2030, but EVs only represent 23.9% of car registrations this year, per Society of Motor Manufacturers and Traders (SMMT) data. Manufacturers have incurred heavy costs trying to meet original targets, while government incentives like the Electric Car Grant seek to drive uptake. Despite the easing, the 2030 ban on new pure-combustion cars remains, with hybrids and electric vehicles still allowed. All cars sold from 2035 must be electric under current plans. The government is set for consultation before confirming changes, which industry leaders view as a pragmatic shift reflecting slower EV market adoption.